Efficacy and safety of a four-week treatment with budesonide/formoterol in patients with cough variant asthma: Open-label, randomized and parallel-group study compared with budesonide.

Trial Profile

Efficacy and safety of a four-week treatment with budesonide/formoterol in patients with cough variant asthma: Open-label, randomized and parallel-group study compared with budesonide.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Apr 2013

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Budesonide
  • Indications Asthma
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 31 Mar 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 17 Apr 2012 Additional lead trial investigator (Hisako Matsumoto) identified as reported by University Hospital Medical Information Network - Japan.
    • 19 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top